Document Detail


Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population.
MedLine Citation:
PMID:  23288726     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis in the process of tumor growth and metastasis. Different VEGF gene polymorphisms have been shown to result in different VEGF protein expression in cancer cells and tumor angiogenic activity. We conducted a case-control study to evaluate the genetic effects of VEGF-460C/T polymorphism on the development of lung cancer. One hundred and twenty-six lung cancer patients and 160 sex-, age-, and ethnic-matched healthy controls were recruited for this study. The genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Odds ratios (ORs) and 95 % confidence intervals (CI) were calculated by logistic regression analysis. Our study showed that the TT genotype was associated with increased lung cancer risk than those with the CC (OR = 1.99, 95 % CI 1.05-3.77) or CT/CC (OR = 1.89, 95 % CI 1.17-3.06) genotype. Moreover, it was observed that the TT genotype associated with the advanced stage among lung cancer patients (TT vs. CC: OR = 3.09, 95 % CI 1.10-8.66). More studies are needed to detect VEGF-460C/T polymorphism and its association with lung cancer in different ethnic populations incorporated with environmental exposures.
Authors:
Shi-Fang Sun; Da-Bing Huang; Chao Cao; Zai-Chun Deng
Related Documents :
22272666 - Colorectal cancer screening of high-risk populations: a national survey of physicians.
22975646 - Learning curve of laparoscopy spleen-preserving splenic hilar lymph node dissection for...
23703946 - Imaging systems and urine specimens: a new match made?
23632816 - Age-specific occurrence of hpv16- and hpv18-related cervical cancer.
24351336 - Increase in antibody dependent cellular cytotoxicity (adcc) in a patient with advanced ...
25107706 - Change or die: targeting adaptive signaling to kinase inhibition in cancer cells.
Publication Detail:
Type:  Journal Article     Date:  2013-01-04
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  410     Citation Subset:  IM    
Affiliation:
Department of Respiratory Medicine, Affiliated Hospital, Medical College, Ningbo University, Ningbo, 315020, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Heparanase overexpression participates in tumor growth of cervical cancer in vitro and in vivo.
Next Document:  Surgical Treatment of Simultaneous Rupture of the Anterior Cruciate Ligament and the Patellar Tendon...